Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GBT

Global Blood Therapeutics (GBT) Stock Price, News & Analysis

Global Blood Therapeutics logo

About Global Blood Therapeutics Stock (NASDAQ:GBT)

Advanced Chart

Key Stats

Today's Range
$68.49
$68.49
50-Day Range
$68.07
$68.49
52-Week Range
$21.65
$73.02
Volume
74 shs
Average Volume
2.07 million shs
Market Capitalization
$4.62 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Global Blood Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

GBT MarketRank™: 

Global Blood Therapeutics scored higher than 7% of companies evaluated by MarketBeat, and ranked 920th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Global Blood Therapeutics.

  • Earnings Growth

    Earnings for Global Blood Therapeutics are expected to grow in the coming year, from ($4.71) to ($3.08) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Global Blood Therapeutics is -13.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Global Blood Therapeutics is -13.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Global Blood Therapeutics has a P/B Ratio of 22.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for GBT.
  • Dividend Yield

    Global Blood Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Global Blood Therapeutics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for GBT.
  • Search Interest

    2 people have searched for GBT on MarketBeat in the last 30 days.
Receive GBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Blood Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GBT Stock News Headlines

Global Blood Therapeutics Inc (GBT)
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
GBT Technologies to acquire Nexus Workspaces from CGI
See More Headlines

GBT Stock Analysis - Frequently Asked Questions

Global Blood Therapeutics, Inc. (NASDAQ:GBT) issued its quarterly earnings results on Thursday, November, 4th. The company reported ($1.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.10) by $0.03. The business's revenue for the quarter was up 41.1% compared to the same quarter last year.

Global Blood Therapeutics (GBT) raised $102 million in an initial public offering on Wednesday, August 12th 2015. The company issued 6,000,000 shares at $16.00-$18.00 per share. Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and Cowen and Company and Wedbush PacGrow were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Blood Therapeutics investors own include NVIDIA (NVDA), Micron Technology (MU), Alibaba Group (BABA), Meta Platforms (META), Intel (INTC), Bristol Myers Squibb (BMY) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/04/2021
Today
8/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GBT
CIK
1629137
Fax
N/A
Employees
457
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$303.09 million
Net Margins
-137.30%
Pretax Margin
-137.01%
Return on Equity
-170.37%
Return on Assets
-39.24%

Debt

Debt-to-Equity Ratio
4.92
Current Ratio
6.88
Quick Ratio
6.17

Sales & Book Value

Annual Sales
$194.75 million
Price / Sales
23.73
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
22.46

Miscellaneous

Outstanding Shares
67,476,000
Free Float
64,170,000
Market Cap
$4.62 billion
Optionable
Optionable
Beta
0.45

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:GBT) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners